Address: Str.Nicolae Caramfil,nr. 71-73,Et.5,Sector 1,Bucuresti, Romania
Tel: +40 21 224 00 32
Web: http://www.drreddys.ro/
Company description
Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company.
As a fully integrated pharmaceutical company, Dr Reddy’s provides medicines through three core businesses:
Pharmaceutical Services and Active Ingredients, comprising our Active Pharmaceuticals and Custom Pharmaceuticals businesses;
Global Generics, which includes branded and unbranded generics; and
Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations, and Generic Biopharmaceuticals.
Dr. Reddy’s Laboratories first entered the Romanian market in 1995. Today, Romania is one of the G8 focus countries for the Group, generating nearly USD 20 million in annual turnover.
Products and services
Dr Reddy’s products are marketed globally, with a focus on India, US, Europe and Russia. Dr. Reddy’s conducts NCE research in the areas of metabolic disorders, cardiovascular indications, anti-infectives and inflammation.